Both in Pharmaceuticals
Xencor vs Arcus Biosciences
Over the past year XNCR returned +113.9% and RCUS returned −10.6%; their daily moves had a correlation of 0.43.
XNCR +113.9% RCUS −10.6%Growth of $1, one year, split-adjusted
| Metric | XNCR | RCUS |
|---|---|---|
| Price | $29.82 | $18.19 |
| Market cap | $2.22B | $2.32B |
| Today | +2.09% | −2.26% |
| 1 month | +20.4% | −27.9% |
| 6 months | +135.0% | −29.2% |
| Year to date | +94.8% | −23.7% |
| 1 year | +103.3% | −10.3% |
| Revenue growth (YoY) | +17.5% | −74.4% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −42.4% | −222.0% |
| P/E (TTM) | — | — |
| Price / sales | 21.1× | 19.8× |
| Net cash | $351.6M | $601.0M |
| Dividend yield | — | — |
| Volatility (60d) | 62.4% | 62.7% |
| Short % of float | 17.0% | 13.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).